Benzothiazoles having histamine H3 receptor activity
Details for Australian Patent Application No. 2007229492 (hide)
International Classifications
Event Publications
4 September 2008 PCT application entered the National Phase
PCT publication WO2007/110364 Priority application(s): WO2007/110364
13 November 2008 Alteration of Name
The name of the applicant has been altered to High Point Pharmaceuticals, LLC Amendments
3 November 2011 Application Accepted
Published as AU-B-2007229492
1 March 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007229502-Benzimidazole derivatives and their use for modulating the GABAA receptor complex
2007229491-Methods for treating cognitive and other disorders
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser